Oracle (NYSE:ORCL) EVP Sells 2,631 Shares

Oracle Corporation (NYSE:ORCLGet Free Report) EVP Maria Smith sold 2,631 shares of the business’s stock in a transaction dated Tuesday, September 22nd. The stock was sold at an average price of $151.70, for a total value of $399,122.70. Following the transaction, the executive vice president directly owned 64,357 shares of the company’s stock, valued at approximately $9,762,956.90. This represents a 3.93% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website.

Oracle Stock Down 3.2%

ORCL stock traded down $4.76 during trading on Wednesday, hitting $144.44. 22,584,953 shares of the company’s stock were exchanged, compared to its average volume of 30,638,724. The stock has a market capitalization of $436.75 billion, a price-to-earnings ratio of 22.64, a PEG ratio of 1.06 and a beta of 1.74. Oracle Corporation has a 52-week low of $114.50 and a 52-week high of $322.54. The company has a current ratio of 1.17, a quick ratio of 1.17 and a debt-to-equity ratio of 1.89. The business has a 50-day moving average price of $142.39 and a two-hundred day moving average price of $160.34.

Oracle (NYSE:ORCLGet Free Report) last issued its quarterly earnings data on Thursday, September 10th. The enterprise software provider reported $1.92 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.74 by $0.18. Oracle had a return on equity of 48.85% and a net margin of 26.36%.The company had revenue of $19.34 billion for the quarter, compared to analyst estimates of $19.13 billion. During the same quarter last year, the company posted $1.47 earnings per share. The business’s quarterly revenue was up 29.6% compared to the same quarter last year. Oracle has set its Q2 2027 guidance at 1.850-1.930 EPS and its FY 2027 guidance at 8.100-8.100 EPS. As a group, equities research analysts expect that Oracle Corporation will post 6.67 EPS for the current year.

Oracle Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 23rd. Investors of record on Friday, October 9th will be given a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 1.4%. The ex-dividend date is Friday, October 9th. Oracle’s dividend payout ratio (DPR) is 31.35%.

Institutional Investors Weigh In On Oracle

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. QRG Capital Management Inc. lifted its stake in Oracle by 12.9% during the second quarter. QRG Capital Management Inc. now owns 300,056 shares of the enterprise software provider’s stock worth $43,973,000 after purchasing an additional 34,397 shares during the last quarter. Envestnet Portfolio Solutions Inc. grew its holdings in shares of Oracle by 13.8% during the second quarter. Envestnet Portfolio Solutions Inc. now owns 117,271 shares of the enterprise software provider’s stock valued at $17,186,000 after purchasing an additional 14,208 shares during the last quarter. Premier Financial Group acquired a new stake in shares of Oracle during the 2nd quarter worth approximately $101,000. Security National Bank of Sioux City Iowa IA lifted its holdings in shares of Oracle by 42.1% in the 2nd quarter. Security National Bank of Sioux City Iowa IA now owns 31,833 shares of the enterprise software provider’s stock worth $4,665,000 after purchasing an additional 9,424 shares during the last quarter. Finally, Bullseye Investment Management LLC acquired a new position in Oracle during the 2nd quarter valued at approximately $1,676,000. Hedge funds and other institutional investors own 42.44% of the company’s stock.

Trending Headlines about Oracle

Here are the key news stories impacting Oracle this week:

  • Positive Sentiment: Oracle expanded its Digital Assets Data Nexus, adding payment execution integrations, wallet and smart-contract controls, Swift Ledger integration, and AI-assisted risk oversight. The offering could help banks modernize digital-money operations and create additional demand for Oracle’s banking software. Oracle Expands Digital Assets Data Nexus
  • Positive Sentiment: New Oracle Health initiatives apply AI to oncology electronic health records, revenue-cycle management, and life-sciences research. These products may strengthen Oracle’s position in healthcare technology and support longer-term recurring cloud revenue. Oracle Oncology EHR
  • Positive Sentiment: Oracle is collaborating with the Buck Institute on aging research using Oracle Life Sciences Data Intelligence, while a Wipro partnership expands managed pharmacovigilance services. The deals support Oracle’s strategy of monetizing real-world healthcare data and specialized cloud workloads. Oracle and Buck Institute Collaboration
  • Neutral Sentiment: Oracle’s reported 50,000-GPU deployment and relationship with AMD highlight strong AI infrastructure demand, but investors are still assessing whether the resulting revenue and returns can justify the required capital spending. AMD and Oracle GPU Deployment
  • Negative Sentiment: Heavy debt issuance to fund data-center and AI expansion is reportedly carrying a 37-basis-point financing premium. Higher borrowing costs could pressure cash flow and reduce the near-term returns from Oracle’s cloud investments. Oracle AI Debt Financing Costs
  • Negative Sentiment: Reports of more than 500 layoffs in Oracle’s cloud infrastructure division, including engineers and data-center support staff, raise questions about operating efficiency, workforce requirements, and execution during rapid expansion. Oracle Cloud Layoffs

Analyst Ratings Changes

Several research analysts have issued reports on ORCL shares. Freedom Broker cut their price objective on Oracle from $210.00 to $205.00 and set a “buy” rating for the company in a research report on Monday, September 14th. Jefferies Financial Group reduced their price objective on shares of Oracle from $320.00 to $290.00 and set a “buy” rating on the stock in a research note on Wednesday, September 2nd. Sanford C. Bernstein reissued an “outperform” rating on shares of Oracle in a research note on Wednesday, September 2nd. Morgan Stanley increased their target price on Oracle from $207.00 to $210.00 and gave the stock an “equal weight” rating in a research report on Friday, September 4th. Finally, DA Davidson reissued a “buy” rating and issued a $225.00 price target on shares of Oracle in a research note on Friday, September 11th. Two equities research analysts have rated the stock with a Strong Buy rating, thirty have given a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, Oracle has a consensus rating of “Moderate Buy” and a consensus price target of $252.58.

Get Our Latest Report on ORCL

Oracle Company Profile

(Get Free Report)

Oracle Corporation is a global enterprise technology company that develops and provides database software, cloud infrastructure, business applications and related technology services. Its offerings help organizations manage data, run applications, support business operations and build technology environments across on-premises, hybrid and cloud-based settings.

The company’s products include Oracle Database, MySQL, Java, Oracle Cloud Infrastructure and a broad portfolio of cloud applications for enterprise resource planning, financial management, human resources, supply chain management, customer experience and industry-specific operations.

Featured Stories

Insider Buying and Selling by Quarter for Oracle (NYSE:ORCL)

Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.